UK-based CPH2 has today (April 20) announced its inaugural financial results and report for 2022, with eyes on commercialisation.
The company, which developed its Membrane-Free Electrolyser (MFE) technology, revealed after admission to the London Stock Exchange-operated AIM market in February last year (2022), it raised gross proceeds of £30.5m ($37.9m).
With a year-end net asset position of £25.3m, the company said £15.3m ($19.04m) was in cash or current assets investments (bank deposits).
... to continue reading you must be subscribed
